care daybook✳

SURMOUNT-1 DXA substudy

GLP-1 muscle loss: what body-composition studies measure

How to read body-composition evidence without confusing lean tissue, skeletal muscle and everyday strength.

Start with the measurement

A scale answers a narrow question: what does the body weigh today? It does not identify which tissues changed or how well someone can move through daily life. Body-composition studies add information, but their terminology can sound more precise than the clinical conclusion actually is. The most useful first step is to separate the quantity measured from the outcome a reader cares about.

The SURMOUNT-1 body-composition substudy used dual-energy X-ray absorptiometry, or DXA, at baseline and week 72. The reported analysis included 160 adults with paired measurements: 124 receiving pooled tirzepatide doses and 36 receiving placebo. Trial doses were 5, 10 or 15 mg weekly. This is a small subset of a larger trial, not a measurement of every participant.[1]

Lean mass does not mean strength

Three questions that need different evidence

Body weightWhat changed on the scale?
Body compositionWhich measured compartments changed?
Physical functionWhat can the person comfortably do?
Conceptual illustration. DXA compartment measurements do not directly measure strength or diagnose muscle disease.

“Lean mass” is not a synonym for skeletal muscle. A DXA estimate includes non-fat soft tissues and their water; it does not directly test strength. A change in that compartment therefore needs interpretation rather than relabeling as a measured loss of functional muscle. Likewise, a more favorable proportion of lean tissue does not mean its absolute amount increased.[1]

Three common reading errors
What to separateWhat it means for your reading
“Lean mass fell, so strength fell by the same amount”A tissue estimate and a performance measurement answer different questions.
“The lean percentage rose, so no lean tissue was lost”A proportion can rise while its absolute amount falls if another compartment falls more.
“These averages predict my own result”Group means do not show an individual’s baseline, trajectory or function.

An everyday arithmetic example helps: if the whole becomes smaller, a part can occupy a larger share even while that part also shrinks. That statement is mathematics, not a claim about an individual’s body. It explains why a headline about “improved body composition” and a statement about reduced lean mass are not automatically contradictory. Always look for the denominator and the unit before deciding what changed.

Longer-term planning also raises questions about maintaining weight loss. If tiredness is part of your concern, our tirzepatide fatigue explainer separates a reported symptom from its possible causes. For another change that can arise during treatment, read our hair-shedding guide.

Read the evidence with its correction

The publication has a linked correction, DOI 10.1111/dom.70050. We identify that record alongside the original paper so readers can follow the publication history. This guide concentrates on measurement and care-planning interpretation rather than presenting a numerical body-composition target.[2]

A substudy can raise an important follow-up question without answering every question about function, frailty or a particular patient group. Small imaging subsets also deserve attention to who had both measurements available. The right response is neither to dismiss the study nor to turn a percentage into a diagnosis. Ask what additional information would be needed to make the claim you are hearing.

For example, a claim about maintaining the ability to climb stairs needs information about performance, not only a scan. A claim that one treatment preserves more muscle than another needs a suitable comparison, not two percentages lifted from different trials. Different populations, treatment periods and measurement methods can make an apparently tidy side-by-side chart misleading.

Make room for function at follow-up

Our practical interpretation is to bring functional concerns into the conversation in concrete language. “My usual grocery bags feel harder to carry” is more informative than “I think I lost muscle,” because it names the change you have noticed without supplying your own diagnosis. Ask the clinician what assessment, if any, would help explain it. A study chart cannot determine which test or intervention is appropriate for you.

Nutrition and activity support also deserve specific questions when comparing a service. Who provides it? Is a qualified professional available for individual discussion, or is the benefit a collection of general lessons? How does that person communicate with the prescriber? Is the support included in the quoted fee? A list of app features does not tell you how concerns will move between people.

The Form Health review explores a documented clinician-and-dietitian arrangement; the WeightWatchers Clinic review offers another service context to investigate. Neither inclusion implies that a provider has demonstrated the body-composition results of this study. Use our comparison guides and checklist to clarify the actual service before paying.

Keep the plan individual

This evidence does not justify a universal protein target, exercise prescription, scan schedule or medication adjustment. Those choices depend on clinical context. An article can help frame the question while leaving the answer with the professional responsible for care. If a service advertises “muscle protection,” ask what outcome it measured, in whom, and whether the claim concerns that service or an unrelated study.

The useful goal for your next conversation is a shared understanding of progress. Ask which measures the care team uses, what each measure can and cannot tell you, and how a change in daily function would be reviewed. A thoughtful care plan can hold more than one outcome in view without treating every number as a verdict.

Sources

  1. Look M et al. Diabetes, Obesity and Metabolism. 2025;27:2720–2729. DOI: 10.1111/dom.16275. 160-person DXA analysis over 72 weeks; pooled tirzepatide 5, 10 and 15 mg versus placebo ↩
  2. Published correction ↩

Continue your reading.

Weight regain after stopping semaglutide: the STEP 1 extensionTirzepatide maintenance: what SURMOUNT-4 foundSemaglutide and heart health: understanding SELECTDoes tirzepatide cause fatigue? What the label tells us.Semaglutide and constipation: what to ask your care team.GLP-1 hair loss: make sense of shedding and your next stepsGLP-1 nausea: everyday comfort and when to ask for helpSemaglutide weight-loss plateau: what a steady scale can mean

Your choice of next step

Continue to the provider

You can continue to the provider you selected, or consider the optional commercial link below.

Continue to the provider

Optional affiliate alternative

CoreAge Rx

Compare CoreAge Rx’s compounded semaglutide plans and current terms. Compounded drugs are not FDA-approved and are not interchangeable with approved medicines.

Explore CoreAge RxRead our reviewWe may earn a commission through the CoreAge Rx link. Continuing to your original provider is always available above.